It booked other income of Rs 42.1 crore, up 14 per cent from Rs 37.1 crore
Higher demand for coal due to global shortage has helped better auction realisations
Revenue from operations was up at Rs 692.16 crore from Rs 614.87 crore in the year-ago period
Its portfolio consists of 18.7 million square feet comprising 14.3 million square feet of completed area and 4.4 million square feet of future development potential
It had posted a net profit of Rs 377 crore in the same period a year ago
The drug firm had reported a net profit of Rs 606 crore in the July-September period of last fiscal
Its net profit stood at Rs 92.47 crore in the year-ago period
The lender's net interest income improved 12.83 per cent YoY to Rs 35,183 crore for Q2FY23, against Rs 31,184 crore last year
The total income of the company rose to Rs 11,349.44 crore in the quarter from Rs 10,514.74 crore in the same period a year ago.
Provisions of the lender declined 41 per cent YoY to Rs 1,628 crore in Q2FY23.
The bank's gross non-performing assets (NPAs) declined to 9.67 per cent of the gross advances at the end of September 2022 from 14.54 per cent during the same period a year ago.
Profits down 91% in Q2, driven by margin contraction because sales realisation did not keep pace with rise in expenses
The company is confident that it will return to operational profitability in Q3
Shares of Britannia Industries Ltd on Friday settled at Rs 3,801.30 on BSE, 1.46 per cent higher than its previous close
In an emergency bid to secure stable LNG supply, GAIL has sought to expedite talks on short- and long-term supply deals with Gulf firm ADNOC
ABFRL is aggressively expanding its network across brands with Pantaloons adding 21 outlets on a net basis and the branded business taking the store count up by 85
Revenue from operations up 32% to Rs 8,561 cr; chip shortage hinders an even better show
Expenses climbed 4%, while revenue increased 3% to 24.96 billion rupees led by growth in international business
The company is de-risking key product Abraxane in case the Goa plant FDA issue is not cleared immediately
The company earned a profit of 8.57 billion Indian rupees ($103.95 million) in the three months ended Sept. 30 from 6.41 billion rupees in the previous year